RemuzziA.Updating the journal sections for the evolution of research and clinical applications in artificial organs. Int J Artif Organs2016; 39(6): 261–264.
EricksonKFWarrierAWangV.Market consolidation and innovation in US dialysis. Adv Chronic Kidney Dis2022; 29(1): 65–75.
4.
BelloAKOkpechiIGOsmanMA, et al. Epidemiology of haemodialysis outcomes. Nat Rev Nephrol2022; 18: 378–395.
5.
ZimpferDFianeAELarbalestierR, et al. Long-term survival of patients with advanced heart failure receiving an left ventricular assist device intended as a bridge to transplantation: the registry to evaluate the heartware left ventricular assist system. Circ Heart Fail2020; 13(3): e006252
6.
Bekono-NessahIRosenburgABowlesCT, et al. Bleeding and thrombotic complications and their impact on mortality in patients supported with left ventricular assist device for cardiogenic shock. Perfusion2023; 38(8): 1670–1681
7.
Hernández-MenesesMSandovalEFarreroM.Left ventricular assist device infections: from epidemiology to treatment. JHLT Open2025; 27(11): 100451
8.
HimmelfarbJVanholderRMehrotraR, et al. The current and future landscape of dialysis. Nat Rev Nephrol2020; 16(10): 573–585.
